Track record · closed signal

Pfizer Inc. (PFE) — closed signal from January 6, 2026

Near target Published before the outcome was known, scored automatically when the window closed on April 6, 2026 — +8.2% at the close.

Predicted vs. what happened

PFE price · publication thesis → realized outcomesplit-adjusted

$25.00 – $26.10Entry zone — fair-value band

$25.72Published — price the day we called it

$28.80Target — the price the thesis aimed for

$28.75Peak — highest point inside the window, not a realized return

$27.83Window close — end-of-window price, context only

What happened

Near target

Came within reach: 98% of the predicted growth at its peak, just short of the target.

At window close

+8.2%

realized, from the publication price to the last close inside the window

Peak gain

+11.8%

peak, from the publication price — not a realized return

S&P 500, same window

-4.5%

SPY over the identical days, dividend-adjusted

Window close

$27.83

last close inside the window, ended April 6, 2026

Peak price

$28.75

peak on April 2, 2026 — not a realized return

Days to target

—

The thesis — published January 6, 2026

Predicted growth

+12%

over the measurement window

Target price

$28.80

the price the thesis aimed for

Entry zone

$25.00 – $26.10

the fair-value band we waited for

Price at publication

$25.72

published January 6, 2026

Confidence

72%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

Pfizer could see a short-term bounce. Announced price increases for many drugs improve the near-term story, and its dividend appeal can draw cautious buyers. The stock has fallen for a while, so wait for selling to calm before buying. This looks like a rebound trade, not a long-term recovery; policy reactions and weak follow-through are the main risks.

Primary drivers

Planned price increases may help near-term sales and talk about revenue
Dividend and defensive appeal can draw cautious investors
Recent heavy selling makes a bounce more likely if it steadies
Easy to trade size due to high daily stock volume

How it played out

PFE: target stayed just out of reach

Lyra published PFE at $25.72 on 2026-01-06 as a short-term rebound trade with expected growth of 12%. The thesis pointed to planned price increases, dividend and defensive appeal, recent heavy selling, and high daily stock volume. It also named policy reactions and weak follow-through as the main risks.

Inside the 2026-01-06 to 2026-04-06 window, PFE rose as high as $28.75 on 2026-04-02, a peak gain of 11.8%. The target was $28.80. It never got there. The stock ended at $27.83. The thesis mostly played out, but it missed the stated target.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All PFE signals